FDA NDC Directory · JSON-LD · Markdown

NICORETTE

NDC 0135-0511 · HUMAN OTC DRUG · LOZENGE

Generic namenicotine polacrilex
Labeler / ManufacturerHaleon US Holdings LLC
Marketing categoryNew Drug Application (innovator) · App NDA021330
Dosage form / routeLOZENGE · ORAL
Active ingredientsNICOTINE (4 mg/1)
Marketing started20101019
Package count3

External sources

Source: openFDA. Public-domain (CC0).